与肉毒神经毒素A型注射相关的结节形成:23名患者的潜在触发因素
Laila Hassan1, George Kroumpouzos2,3
1From the Department of Aesthetic Medicine, Khyber Medical University, Peshawar, Pakistan.
Plastic and reconstructive surgery. Global open
|September 24, 2025
概括
在A型肉毒神经毒素 (BoNTA) 注射后的结节可能是立即的过敏反应. 需要进一步的研究来探索与COVID-19疫苗接种的联系,但这些结节通常是良性的.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 化品的程序 化品的程序
背景情况:
- 在A型肉毒神经毒素 (BoNTA) 治疗后,注射部位的结节是最近报告的一种并发症.
- 这种并发症会引起患者的痛苦,原因不明,进展和管理.
- 之前的研究并没有彻底研究这个现象.
研究的目的:
- 详细介绍一系列在BoNTA治疗后出现结节的患者.
- 调查潜在的触发因素,包括感染,疫苗接种和稀释剂成分.
- 评估这些节点的管理策略和解决时间.
主要方法:
- 23名女性参与者 (35-65岁) 的回顾性病例系列.
- 在BoNTA注射后24小时内记录了结节的形成.
- 调查潜在的触发因素,评估治疗结果.
主要成果:
- 所有参与者在BoNTA治疗后24小时内都出现了结节.
- 所有患者在BoNTA之前都接种了COVID-19疫苗和助推剂.
- 使用抗生素,酸酶,类固醇或抗组胺剂的管理导致在几天到一个月内得到解决.
结论:
- 在BoNTA后的结节形成可能代表了立即的过敏反应.
- 与COVID-19疫苗接种的潜在关联需要进一步调查.
- 患者应被告知这些结节的良性性质.
更多相关视频
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.1K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.1K
Neuromuscular Junction And Blockade
4.8K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
4.8K
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
918
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
918
Local Anesthetics: Adverse Effects
757
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
757


